Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Stebbing

Showing results (131-140 of 504) with videos related to

Pageof 51
Sort By:
Pharmacogenomics|December 26, 2006
Role of CYP2D6 testing in selection of endocrine therapy for breast cancerJustin Stebbing, Vered Stearns, Nancy E Davidson
Future Oncology (London, England)|December 13, 2006
Clots and cancerS Nasim Ali, Justin Stebbing, Danish Mazhar
Oncogene|February 18, 2026
Modelling adipose tissue-cancer crosstalk: a three-dimensional perspectiveGabriele Strusi, Caterina M Suelzu, Justin Stebbing
Clinical Evidence|September 16, 2006
Breast cancer (non-metastatic)Alan Rodger, Justin Stebbing, Alistair M Thompson
Expert Opinion on Drug Safety|August 18, 2020
Reply to letter to the editor: baricitinib and toxicity is a rare occurrenceLing Peng, Justin Stebbing, Ying-Jie Wang
The Lancet. Infectious Diseases|April 7, 2020
Baricitinib for COVID-19: a suitable treatment? - Authors' replyPeter J Richardson, Mario Corbellino, Justin Stebbing
Clinical Evidence|September 2, 2005
Breast cancer (non-metastatic)J Michael Dixon, Alan Rodger, Justin Stebbing
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
The Emergence of Baricitinib: A Story of Tortoises Versus HaresHeinz-Josef Lenz, Peter Richardson, Justin Stebbing
Expert Opinion on Biological Therapy|September 12, 2019
Clinical development of CT-P6 in HER2 positive breast cancerChen Fu, Justin Stebbing, Francisco J Esteva
Breast Cancer Research and Treatment|January 3, 2008
Cardiotoxicity and anthracyclinesJustin Stebbing, Alison Jones, Peter Barrett-Lee
Pageof 51

Showing results (131-140 of 504) with videos related to

Sort By:
Pageof 51
Pharmacogenomics|December 26, 2006
Role of CYP2D6 testing in selection of endocrine therapy for breast cancerJustin Stebbing, Vered Stearns, Nancy E Davidson
Future Oncology (London, England)|December 13, 2006
Clots and cancerS Nasim Ali, Justin Stebbing, Danish Mazhar
Oncogene|February 18, 2026
Modelling adipose tissue-cancer crosstalk: a three-dimensional perspectiveGabriele Strusi, Caterina M Suelzu, Justin Stebbing
Clinical Evidence|September 16, 2006
Breast cancer (non-metastatic)Alan Rodger, Justin Stebbing, Alistair M Thompson
Expert Opinion on Drug Safety|August 18, 2020
Reply to letter to the editor: baricitinib and toxicity is a rare occurrenceLing Peng, Justin Stebbing, Ying-Jie Wang
The Lancet. Infectious Diseases|April 7, 2020
Baricitinib for COVID-19: a suitable treatment? - Authors' replyPeter J Richardson, Mario Corbellino, Justin Stebbing
Clinical Evidence|September 2, 2005
Breast cancer (non-metastatic)J Michael Dixon, Alan Rodger, Justin Stebbing
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
The Emergence of Baricitinib: A Story of Tortoises Versus HaresHeinz-Josef Lenz, Peter Richardson, Justin Stebbing
Expert Opinion on Biological Therapy|September 12, 2019
Clinical development of CT-P6 in HER2 positive breast cancerChen Fu, Justin Stebbing, Francisco J Esteva
Breast Cancer Research and Treatment|January 3, 2008
Cardiotoxicity and anthracyclinesJustin Stebbing, Alison Jones, Peter Barrett-Lee
Pageof 51